|
1
|
Lambert R and Hainaut P: The
multidisciplinary management of gastrointestinal cancer.
Epidemiology of oesophagogastric cancer. Best Pract Res Clin
Gastroenterol. 21:921–945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holmes RS and Vaughan TL: Epidemiology and
pathogenesis of esophageal cancer. Semin Radiat Oncol. 17:2–9.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu S: Research progress on etiology of
esophageal cancer. A specially invited set of reports for Annual
Meeting Seminar of the Tenth China Association for Science and
Technology. 129–132. 2008.
|
|
4
|
Matullo G, Palli D, Peluso M, et al:
XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts
in a sample of healthy subjects. Carcinogenesis. 22:1437–1445.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishikawa T, Zhang SS, Qin X, Takahashi Y,
Oda H, Nakatsuru Y and Ide F: DNA repair and cancer: lessons from
mutant mouse modle. Cancer Sci. 95:112–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Egly JM: The 14th Datta Lecture. TFIIH:
from transcription to clinic. FEBS Lett. 498:124–128. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lehmann AR: The xeroderma pigmentosum
group D (XPD) gene: one gene, two functions, three diseases. Genes
Dev. 15:15–23. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XW, Vermeulen W, Coursen JD, et al:
The XPB and XPD DNA helicases are components of the p53-mediated
apoptosis pathway. Genes Dev. 10:1219–1232. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Boer J, Donker I, de Wit J, Hoeijmakers
JH and Weeda G: Disruption of the mouse xeroderma pigmentosum
group D DNA repair/basal transcription gene results in
preimplantation lethality. Cancer Res. 58:89–94. 1998.
|
|
10
|
Manuguerra M, Saletta F, Karagas MR,
Berwick M, Veglia F, Vineis P and Matullo G: XRCC3 and XPD/ERCC2
single nucleotide polymorphisms and the risk of cancer: a HuGe
review. Am J Epidemiol. 164:297–302. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sturgis EM, Zheng R, Li L, Castillo EJ,
Eicher SA, Chen M, Strom SS, Spitz MR and Wei Q: XPD/ERCC2
polymorphism and risk of head and neck cancer: a case-control
analysis. Carcinogenesis. 21:2219–2223. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Butkiewicz D, Rusin M, Enewold L, Shields
PG, Chorazy M and Harris CC: Genetic polymorphisms in DNA repairs
genes and risk of lung cancer. Carcinogenesis. 22:593–597. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dybdahl M, Vogel U, Frentz G, Wallin H and
Nexø BA: Polymorphisms in the DNA repair gene XPD: correlations
with risk and age at onset of basal cell carcinoma. Cancer
Epidemiol Biomarkers Prev. 8:77–81. 1999.PubMed/NCBI
|
|
14
|
Tang D, Cho S, Rundle A, Chen S, Phillips
D, Zhou J, Hsu Y, Schnabel F, Estabrook A and Perera FP:
Polymorphisms in the DNA repair enzyme XPD are associated with
increased levels of PAH-DNA adducts in a case-control study of
breast cancer. Breast Cancer Res Treat. 75:159–166. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruzzo A, Canestrari E, Maltese P, et al:
Polymorphisms in genes involved in DNA repair and metabolism of
xenobiotics in individual susceptibility to sporadic diffuse
gastric cancer. Clin Chem Lab Med. 45:822–828. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye W, Kumar R, Bacova G, Lagergren J,
Hemminki K and Nyrén O: The XPD 751Gln allele is associated with an
increased risk for esophageal adenocarcinoma: a population-based
case-control study in Sweden. Carcinogenesis. 27:1835–1841. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou R, Li Y, Wang N, et al: Association
study on mononucleotide polymorphism of XPD gene and risk of
esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma.
Tumor. 27:118–123. 2007.
|
|
18
|
Chen M, Wang J and Guo G: The correlation
of repair gene XPD Lys751Gln for DNA damage, XRCC1 Arg399Gln
polymorphism mononucleotide with genetic susceptibility of
esophageal cancer. Fudan University (Med Sci). 35:273–278.
2008.
|
|
19
|
Wu X, Wang P, Yun Y, et al: The
relationship between esophageal squamous cell carcinoma in Henan
Han Chinese and XPD gene polymorphism. Public Health of China.
28:446–449. 2012.(In Chinese).
|
|
20
|
Tse D, Zhai R, Zhou W, Heist RS, Asomaning
K, Su L, Lynch TJ, Wain JC, Christiani DC and Liu G: Polymorphisms
of the NER pathway genes, ERCCI and XPD are associated with
esophageal adenocarcinoma risk. Cancer Causes Control.
19:1077–1083. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JM, Lee YC, Yang SY, Yang PW, Luh SP,
Lee CJ, Chen CJ and Wu MT: Genetic polymorphisms of XRCC1 and risk
of the esophageal cancer. Int J Cancer. 95:240–246. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lunn RM, Helzlsouer KJ, Parshad R, Umbach
DM, Harris EL, Sanford KK and Bell DA: XPD polymorphisms: effects
on DNA repair proficiency. Carcinogenesis. 21:551–555. 2000.
View Article : Google Scholar : PubMed/NCBI
|
